Formulations and methods for the treatment and/or amelioration of symptoms
of inflammatory conditions and associated systemic inflammatory responses
are described herein. The compositions comprise a non-alpha tocopherol
(especially gamma-, beta-, or delta-tocopherol) and one or more of an
omega-3 fatty acid, such as docosahexaenoic acid (DHA) or a flavonoid.
